News
Print
May 25, 2010
Chairman/CEO Thomas A. Moore to Discuss Clinical Trial Progress
Place: Hard Rock Hotel, Hollywood, Florida | Date: June 7, 2010 |Time: 9:30 A.M. EDT
North Brunswick, NJ – May 25, 2010 – Chairman/CEO Thomas A. Moore of Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, will present at the Noble Financial Sixth Annual Equity Conference at 9:30a.m. EDT on June 7, 2010 at the Hard Rock Hotel in Hollywood, Florida.
The presentation will be webcast – audio, video, PowerPoint - live, and available for viewing at www.advaxis.com or through the Noble Financial websites www.ontrack10.com or www.nobleresearch.com.
For those interested in participating in the webcast, please register at least 10 minutes prior to the start of the presentation to ensure timely access. You will need the SilverLight viewer (a free download from presentation link) to participate. In addition, the webcast and associated collateral material(s) will be archived on the Company’s website for 90 days following the event.
About Noble Financial
Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service investment banking boutique focused on small-cap, emerging growth companies. The company has offices in New York, Boston, New Jersey, St Louis and Boca Raton.
About Advaxis, Inc.
Advaxis is a biotechnology company developing proprietary, live, attenuated Listeria monocytogenes (Listeria) vaccines that deliver engineered tumor antigens, which stimulate multiple, simultaneous immunological mechanisms to fight cancer. Today, the Company has nine (9) distinct, cancer-fighting constructs in various stages of development, directly and through strategic collaborations with such recognized sites of excellence as the City of Hope, the Roswell Park Cancer Institute, the National Cancer Institute, the University of Pittsburgh and Cancer Research – UK. Advaxis’ technology was developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsylvania and chairperson of Advaxis’ scientific advisory board.
Please visit the Company’s portals: advaxis.com | facebook | twitter | LinkedIn
